| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 09/05/2024 | 14:00 | GlobeNewswire Inc. | Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients | NASDAQ:AKYA | Akoya BioSciences Inc |
| 06/05/2024 | 14:00 | GlobeNewswire Inc. | Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts | NASDAQ:AKYA | Akoya BioSciences Inc |
| 02/05/2024 | 14:00 | GlobeNewswire Inc. | Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows | NASDAQ:AKYA | Akoya BioSciences Inc |
| 22/04/2024 | 22:05 | GlobeNewswire Inc. | Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024 | NASDAQ:AKYA | Akoya BioSciences Inc |
| 05/04/2024 | 14:00 | GlobeNewswire Inc. | Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale | NASDAQ:AKYA | Akoya BioSciences Inc |
| 04/03/2024 | 23:18 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AKYA | Akoya BioSciences Inc |
| 04/03/2024 | 22:05 | GlobeNewswire Inc. | Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook | NASDAQ:AKYA | Akoya BioSciences Inc |
| 04/03/2024 | 12:01 | Edgar (US Regulatory) | Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] | NASDAQ:AKYA | Akoya BioSciences Inc |
| 02/03/2024 | 03:58 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AKYA | Akoya BioSciences Inc |
| 12/02/2024 | 15:11 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:AKYA | Akoya BioSciences Inc |
| 08/02/2024 | 22:05 | GlobeNewswire Inc. | Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference | NASDAQ:AKYA | Akoya BioSciences Inc |
| 18/01/2024 | 14:00 | GlobeNewswire Inc. | Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases | NASDAQ:AKYA | Akoya BioSciences Inc |
| 10/01/2024 | 14:00 | GlobeNewswire Inc. | Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board | NASDAQ:AKYA | Akoya BioSciences Inc |
| 08/01/2024 | 21:57 | Dow Jones News | Akoya Biosciences Shares Jump on 2024 Outlook, Thermo Fisher Deal | NASDAQ:AKYA | Akoya BioSciences Inc |
| 07/01/2024 | 14:00 | GlobeNewswire Inc. | Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook | NASDAQ:AKYA | Akoya BioSciences Inc |
| 07/01/2024 | 14:00 | GlobeNewswire Inc. | Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow | NASDAQ:AKYA | Akoya BioSciences Inc |
| 07/01/2024 | 14:00 | GlobeNewswire Inc. | Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform | NASDAQ:AKYA | Akoya BioSciences Inc |
| 20/12/2023 | 14:05 | GlobeNewswire Inc. | Akoya to Participate at 42nd Annual J.P. Morgan Healthcare Conference | NASDAQ:AKYA | Akoya BioSciences Inc |
| 19/12/2023 | 22:23 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:AKYA | Akoya BioSciences Inc |
| 08/11/2023 | 22:00 | GlobeNewswire Inc. | Akoya Reports Record Revenue in the Third Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance | NASDAQ:AKYA | Akoya BioSciences Inc |
| 02/11/2023 | 13:00 | GlobeNewswire Inc. | Akoya to Participate at Three Upcoming Investor Conferences | NASDAQ:AKYA | Akoya BioSciences Inc |
| 31/10/2023 | 14:00 | GlobeNewswire Inc. | Akoya Biosciences to Showcase New Spatial Biology 2.0 Solutions and Spatial Phenotyping Data at SITC 2023 | NASDAQ:AKYA | Akoya BioSciences Inc |
| 17/10/2023 | 16:22 | GlobeNewswire Inc. | Akoya Biosciences Announces Peer-Reviewed Publication Using Ultrahigh-Plex Spatial Phenotyping of Head and Neck Cancer to Identify Distinct Immune and Metabolic Signatures | NASDAQ:AKYA | Akoya BioSciences Inc |
| 11/10/2023 | 22:05 | GlobeNewswire Inc. | Akoya to Report Third Quarter 2023 Financial Results on November 8th, 2023 | NASDAQ:AKYA | Akoya BioSciences Inc |
| 19/09/2023 | 14:00 | GlobeNewswire Inc. | Akoya Biosciences Sets a New Standard for Scaling Spatial Biology with the Launch of 2.0 Platforms | NASDAQ:AKYA | Akoya BioSciences Inc |
| 07/08/2023 | 22:05 | GlobeNewswire Inc. | Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance | NASDAQ:AKYA | Akoya BioSciences Inc |
| 07/08/2023 | 14:05 | GlobeNewswire Inc. | Akoya Biosciences Announces Milestone of 1,000 Peer-Reviewed Publications Citing Use of its Spatial Biology Technologies | NASDAQ:AKYA | Akoya BioSciences Inc |
| 12/07/2023 | 14:05 | GlobeNewswire Inc. | Akoya to Report Second Quarter 2023 Financial Results on August 7th, 2023 | NASDAQ:AKYA | Akoya BioSciences Inc |
| 15/06/2023 | 21:32 | Edgar (US Regulatory) | Report of Proposed Sale of Securities (144) | NASDAQ:AKYA | Akoya BioSciences Inc |
| 13/06/2023 | 16:28 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:AKYA | Akoya BioSciences Inc |